SCI Pharmtech, Inc. (TPE:4119)

SCI Pharmtech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	63.57	582.38	942.06	166.83	332.23	633.03
Trading Asset Securities	14.12	110.37	89	97.55	360.4	-
Cash & Short-Term Investments	77.69	692.76	1,031	264.37	692.63	633.03
Cash Growth	-85.71%	-32.81%	290.00%	-61.83%	9.42%	-37.91%
Accounts Receivable	223.08	289.51	307.37	173.57	82.98	337.75
Other Receivables	0.05	-	0.15	31.1	265.59	519.65
Receivables	223.14	289.51	307.52	204.67	348.56	857.4
Inventory	688.55	620.9	529.53	513.43	294.18	380.88
Other Current Assets	68.07	57.22	85.13	59.93	61.93	47.5
Total Current Assets	1,057	1,660	1,953	1,042	1,397	1,919
Property, Plant & Equipment	5,125	4,803	3,912	3,194	2,100	1,503
Long-Term Investments	217.67	237.52	241.62	208.04	124.97	753.65
Other Intangible Assets	31.64	37.77	46.15	54.58	60.29	41.32
Long-Term Deferred Tax Assets	143.82	143.82	153.28	167.25	241.55	263.55
Other Long-Term Assets	277.46	318.06	384.69	294.11	265.64	89.89
Total Assets	6,853	7,201	6,691	4,961	4,190	4,570
Accounts Payable	51.01	58.44	44.25	48.64	33.78	80.88
Accrued Expenses	45.46	116.05	110.72	128.35	121.46	204.76
Short-Term Debt	150.1	0.1	175	112	-	-
Current Portion of Long-Term Debt	437.85	403.44	20	-	-	-
Current Portion of Leases	5.02	2.47	1.95	0.83	1.58	1.34
Current Income Taxes Payable	21.12	85.25	11.54	3.86	-	127.49
Current Unearned Revenue	64.31	94.92	38.37	31.77	41.76	97.3
Other Current Liabilities	185.63	253.72	168.07	444.86	549.35	610.45
Total Current Liabilities	960.51	1,014	569.89	770.32	747.94	1,122
Long-Term Debt	314.69	578.01	842.67	432.36	-	-
Long-Term Leases	44.42	6.37	2.86	0.2	0.57	1.25
Long-Term Unearned Revenue	-	-	-	4.11	-	-
Pension & Post-Retirement Benefits	11.45	11.96	21.54	19.53	16.95	20.44
Long-Term Deferred Tax Liabilities	104.45	104.45	146	103.81	103.81	103.81
Other Long-Term Liabilities	46.41	8.68	7.84	1	-	-
Total Liabilities	1,482	1,724	1,591	1,331	869.26	1,248
Common Stock	1,195	1,195	1,195	953.82	953.82	794.85
Additional Paid-In Capital	2,235	2,235	2,234	1,357	1,348	1,348
Retained Earnings	1,926	2,037	1,646	1,373	1,067	1,208
Comprehensive Income & Other	15.14	10.07	25.46	-54.73	-48.93	-29.38
Shareholders' Equity	5,371	5,477	5,100	3,629	3,321	3,322
Total Liabilities & Equity	6,853	7,201	6,691	4,961	4,190	4,570
Total Debt	952.08	990.39	1,042	545.38	2.16	2.59
Net Cash (Debt)	-874.39	-297.63	-11.42	-281.01	690.48	630.44
Net Cash Growth	-	-	-	-	9.52%	-37.98%
Net Cash Per Share	-7.30	-2.48	-0.10	-2.61	6.42	5.84
Filing Date Shares Outstanding	119.51	119.51	119.51	107.3	107.3	107.3
Total Common Shares Outstanding	119.51	119.51	119.51	107.3	107.3	107.3
Working Capital	96.94	646.01	1,383	272.08	649.37	796.6
Book Value Per Share	44.94	45.83	42.67	33.82	30.95	30.96
Tangible Book Value	5,340	5,439	5,054	3,575	3,260	3,281
Tangible Book Value Per Share	44.68	45.51	42.29	33.31	30.38	30.58
Land	687.88	687.88	687.88	687.88	825.68	825.68
Buildings	722.9	722.9	707	700.23	684.47	553.52
Machinery	2,504	2,467	1,786	1,185	577.08	576.8
Construction In Progress	2,388	1,965	1,565	1,323	633.3	222.71

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.